Inocul8 is a development company focused on the commercialisation of world leading animal health research to yield high impact livestock vaccines to satisfy the needs of the farming and veterinary communities globally.
The company is a wholly owned subsidiary of The Moredun Research Institute (Moredun), based near Edinburgh in the UK.
We work alongside Moredun to:
The purpose of Inocul8 is to advance a number of exciting new opportunities for vaccines against a range of economically important livestock diseases. The development portfolio includes new or improved vaccines for haemorrhagic septicaemia (Pasteurella multocida ), Caseous Lymphadenitis  and Haemonchus contortus .